Inventor

KALVINSH IVARS

LV32 patents

⚠️ This page may combine multiple inventors who share the name “KALVINSH IVARS”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

KALVINSH IVARS

TOPOTARGET UK LTD

Carbamic acid compounds comprising an ether linkage as HDAC inhibitors

Carbamic acid compounds comprising a sulfonamide linkage as HDAC inhibitors

Carbamic acid compounds comprising a sulfonamide linkage as HDAC inhibitors

Carbamic acid compounds comprising a sulfonamide linkage as HDAC inhibitors

Carbamic acid compounds comprising a sulfonamide linkage as HDAC inhibitors

Carbamic acid compounds comprising an amide linkage as HDAC inhibitors

Carbamic acid compounds comprising a piperazine linkage as HDAC inhibitors

Carbamic acid compounds comprising a piperazine linkage as HDAC inhibitors

Carbamic acid compounds comprising an amide linkage as HDAC inhibitors

Carbamic acid compounds comprising a bicyclic heteroaryl group as HDAC inhibitors

Carbamic acid compounds comprising an ester or ketone linkage as HDAC inhibitors

MERZ PHARMA GMBH & CO KGAA

Unsaturated 1-amino-alkylcyclohexane NMDA, 5HT3, and neuronal nicotinic receptor antagonists

Substituted pyrazolo[1,5-A]pyrimidines as metabotropic glutamate receptor modulators

1-Amino-alkylcyclohexanes as trypanocidal agents

Azabicyclic, azatricyclic and azaspirocyclic derivatives of aminocyclohexane NMDA, 5HT3, and neuronal nicotinic receptor antagonists

Tetrahydroquinolinones and their use as antagonists of metabotropic glutamate receptors

Substituted pyrazolo[1,5-a]pyrimidines as metabotropic glutamate receptor modulators

Azabicyclic, azatricyclic and azaspirocyclic derivatives of aminocyclohexane NMDA, 5HT3, and neuronal nicotinic receptor antagonists

Tetrahydroquinolones and their use as modulators of metabotropic glutamate receptors

MERZ & CO GMBH & CO

1-Amino-alkylcyclohexane NMDA receptor antagonists

1-amino-alkylcyclohexane NMDA receptor antagonists

Pyrido-phtalazin diones and their use against neurological disorders associated with excitotoxicity and malfunctioning of glutamatergic neurotransmission

KALVINSH IVARS

Regeneration of 2,2′-cyclopropylidene-bis (oxazolines)

Method for preparation of 6-[3-(1-adamantyl)-4-methoxyphenyl]-2-naphtoic acid

TAIHO PHARMACEUTICAL CO LTD

Hydroxyl radical scavenger

(unassigned)

Pharmaceutical composition for treating cardiovascular diseases containing 3-(2,2,2-trimethylhydrazinium)propionate and γ-butyrobetaine

GRINDEKS JSC

Meldonium salts, method of their preparation and pharmaceutical composition on their basis

FINN PAUL W

Carbamic acid compounds comprising a bicyclic heteroaryl group as HDAC inhibitors

JOINT STOCK COMPANY JSC “OLAINFARM”

N-carbamoylmethyl-4-(R)-phenyl-2-pyrrolidinone, method of its preparation and pharmaceutical use

VEINBERG GRIGORY

N-Carbamoylmethy1-4-(R)-phenyl-2-pyrrolidinone, method of its preparation and pharmaceutical use

LATVIAN INST OF ORGANIC SYNTHE

Pharmaceutical composition on basis of reverse transcriptase inhibitor and meldonium

DUBURS GUNARS

Pharmaceutical combination of 5-fluorouracil and derivate of 1,4-dihydropyridine and its use in the treatment of cancer